Skip to content
MarketScale
‹ Back to IndustriesHealthcare

5 Ways Healthcare Organizations are Using SDOH to Make a Difference

So much of our overall health is impacted by various socioeconomic factors, which don’t involve ever stepping foot into a doctor’s office, clinic or hospital. Social determinants of health—commonly referred to as SDOH—and healthcare utilization have an evidenced correlation. It’s estimated that as much as 80% of socioeconomic factors determine our health. That’s significant. As…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
5 Ways Healthcare Organizations are Using SDOH to Make a Difference

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

So much of our overall health is impacted by various socioeconomic factors, which don’t involve ever stepping foot into a doctor’s office, clinic or hospital. Social determinants of health—commonly referred to as SDOH—and healthcare utilization have an evidenced correlation. It’s estimated that as much as 80% of socioeconomic factors determine our health. That’s significant. As healthcare organizations—hospitals, health systems and payers—look to curb costs and operate more efficiently, there’s growing evidence pointing to the importance of understanding and addressing SDOH.

Healthcare organizations are using SDOH data in the following ways:

  1. Risk stratification
    Socioeconomic data can be used as one of a few sources to determine what level of risk a patient/member is for high utilization—low risk, moderate risk, rising risk, high risk, etc. In addition to using clinical and claims data, adding socioeconomic data provided by a third party can enhance risk scores built in-house. As a result, organizations can build comprehensive models to segment populations and better manage health outcomes.
  2. Predictive analytics
    By combining socioeconomic data with clinical and claims information, healthcare organizations have been able to identify potential high-risk groups/individuals and determine which socio-clinical interventions to deploy.
  3. Social needs referrals
    SDOH data has been a boon for social workers and care managers. Armed with the right information and tools, they’re able to make accurate referrals to community-based organizations like food banks, transportation services, temporary housing assistance, job training programs and financial aid services. SDOH data helps knock down barriers to care that often lead to bigger, more costly healthcare issues down the line. SDOH data helps solve that. For example, a produce-prescription program in Ward 8 of Washington, DC brought a diversified team together to improve health for pre-diabetic, diabetic and hypertensive individuals who faced food insecurity. The program provides a $20 per week prescription for fruits and vegetables, as well as a nutritional consult. Improvements, such as a decrease in ED visits and hospitalizations and an increase in primary care, have already been seen.
  4. Individual care interventions
    Individual-level datasets inform care managers of specific socioeconomic needs the organization can directly address. For example, without reliable public or personal transportation, patients may skip annual checkups, follow-up visits and recommended screenings. Free rides can be offered to and from the physician’s office to ensure they can make their appointment.

Aggregated data sets are being leveraged to identify which specific neighborhoods would benefit most from SDOH interventions. For example, hospitals in areas with high numbers of homelessness have provided patients facing housing instability with a safe and supportive place to heal after hospital discharge.

FinThrive Social Determinant Risk Attributes delivers individualized (evidence-based data from 90,000+ sources and matched at patient level) and aggregated (neighborhood data down to the ZIP + 4 level) socioeconomic datasets.

Learn more about how FinThrive is advancing health equity through data. See Our SDOH Story.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512